Search research articles
Contact Us
Filters
Showing results (321-330 of 352) with videos related to
Page
of 36
Sort By:
Cancer Research
|
March 12, 2009
Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma
Jim Jinn-Chyuan Sheu, Chun-Hung Hua, Lei Wan, et al.
Science Translational Medicine
|
January 11, 2013
Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers
Isaac Kinde, Chetan Bettegowda, Yuxuan Wang, et al.
Gynecologic Oncology
|
August 4, 2017
Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?
Amanda N Fader, Jennifer Bergstrom, Amelia Jernigan, et al.
Journal of the National Cancer Institute
|
August 28, 2012
Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses
Elisabetta Kuhn, Ren-Chin Wu, Bin Guan, et al.
Cancer Immunology Research
|
January 20, 2019
PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8<sup>+</sup> T-cell Function
Sarah Whelan, Eran Ophir, Maya F Kotturi, et al.
Science Advances
|
September 27, 2024
Combined assembloid modeling and 3D whole-organ mapping captures the microanatomy and function of the human fallopian tube
Ashleigh J Crawford, André Forjaz, Joanna Bons, et al.
Gynecologic Oncology
|
March 7, 2024
Mutations in cancer-relevant genes are ubiquitous in histologically normal endometrial tissue
Deep Pandya, Shannon Tomita, Maria Padron Rhenals, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2023
Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor-Resistant Homologous Recombination-Deficient Ovarian Cancer
Stephanie L Wethington, Payal D Shah, Lainie Martin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 17, 2023
Low-grade serous ovarian cancer: expert consensus report on the state of the science
Rachel N Grisham, Brian M Slomovitz, Nicole Andrews, et al.
Cancer Research
|
August 30, 2020
Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers
Yao-An Shen, Jiaxin Hong, Ryoichi Asaka, et al.
Page
of 36
Search research articles
Search
Showing results (321-330 of 352) with videos related to
Sort By:
Page
of 36
Cancer Research
|
March 12, 2009
Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma
Jim Jinn-Chyuan Sheu, Chun-Hung Hua, Lei Wan, et al.
Science Translational Medicine
|
January 11, 2013
Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers
Isaac Kinde, Chetan Bettegowda, Yuxuan Wang, et al.
Gynecologic Oncology
|
August 4, 2017
Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?
Amanda N Fader, Jennifer Bergstrom, Amelia Jernigan, et al.
Journal of the National Cancer Institute
|
August 28, 2012
Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses
Elisabetta Kuhn, Ren-Chin Wu, Bin Guan, et al.
Cancer Immunology Research
|
January 20, 2019
PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8<sup>+</sup> T-cell Function
Sarah Whelan, Eran Ophir, Maya F Kotturi, et al.
Science Advances
|
September 27, 2024
Combined assembloid modeling and 3D whole-organ mapping captures the microanatomy and function of the human fallopian tube
Ashleigh J Crawford, André Forjaz, Joanna Bons, et al.
Gynecologic Oncology
|
March 7, 2024
Mutations in cancer-relevant genes are ubiquitous in histologically normal endometrial tissue
Deep Pandya, Shannon Tomita, Maria Padron Rhenals, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2023
Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor-Resistant Homologous Recombination-Deficient Ovarian Cancer
Stephanie L Wethington, Payal D Shah, Lainie Martin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 17, 2023
Low-grade serous ovarian cancer: expert consensus report on the state of the science
Rachel N Grisham, Brian M Slomovitz, Nicole Andrews, et al.
Cancer Research
|
August 30, 2020
Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers
Yao-An Shen, Jiaxin Hong, Ryoichi Asaka, et al.
Page
of 36